• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克隆性造血的调节因子及其这种状态的生理后果。

Regulators of clonal hematopoiesis and physiological consequences of this condition.

作者信息

Park Eunbee, Evans Megan A, Walsh Kenneth

机构信息

Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

Hematovascular Biology Center, Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

出版信息

J Cardiovasc Aging. 2024 Jan;4(1). doi: 10.20517/jca.2023.39. Epub 2023 Dec 31.

DOI:10.20517/jca.2023.39
PMID:39119355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11309374/
Abstract

Clonal hematopoiesis (CH) is a prevalent condition that results from somatic mutations in hematopoietic stem cells. When these mutations occur in "driver" genes, they can potentially confer fitness advantages to the affected cells, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers face long-term risks of all-cause mortality and age-associated diseases, including cardiovascular disease and hematological malignancies. While considerable research has focused on understanding the association between CH and these diseases, less attention has been given to exploring the regulatory factors that contribute to the expansion of the driver gene clone. This review focuses on the association between environmental stressors and inherited genetic risk factors in the context of CH development. A better understanding of how these stressors impact CH development will facilitate mechanistic studies and potentially lead to new therapeutic avenues to treat individuals with this condition.

摘要

克隆性造血(CH)是一种普遍存在的状况,由造血干细胞中的体细胞突变引起。当这些突变发生在“驱动”基因中时,它们可能会赋予受影响细胞适应性优势,导致克隆性扩增。虽然大多数突变细胞的克隆性扩增通常被认为是无症状的,因为它们不会影响总体血细胞数量,但CH携带者面临全因死亡率和与年龄相关疾病的长期风险,包括心血管疾病和血液系统恶性肿瘤。尽管大量研究集中于理解CH与这些疾病之间的关联,但对于探索促成驱动基因克隆扩增的调控因素关注较少。本综述聚焦于在CH发展背景下环境应激源与遗传风险因素之间的关联。更好地理解这些应激源如何影响CH发展将有助于进行机制研究,并可能带来治疗这种状况患者的新治疗途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b58/11309374/d5aa66741e39/nihms-1961550-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b58/11309374/d5aa66741e39/nihms-1961550-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b58/11309374/d5aa66741e39/nihms-1961550-f0001.jpg

相似文献

1
Regulators of clonal hematopoiesis and physiological consequences of this condition.克隆性造血的调节因子及其这种状态的生理后果。
J Cardiovasc Aging. 2024 Jan;4(1). doi: 10.20517/jca.2023.39. Epub 2023 Dec 31.
2
Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis.克隆性造血:连接动脉粥样硬化中的衰老和炎症。
Curr Atheroscler Rep. 2023 Mar;25(3):105-111. doi: 10.1007/s11883-023-01083-5. Epub 2023 Feb 18.
3
Clonal Hematopoiesis Analyses in Clinical, Epidemiologic, and Genetic Aging Studies to Unravel Underlying Mechanisms of Age-Related Dysfunction in Humans.临床、流行病学和基因衰老研究中的克隆性造血分析,以揭示人类年龄相关功能障碍的潜在机制。
Front Aging. 2022 Mar 8;3:841796. doi: 10.3389/fragi.2022.841796. eCollection 2022.
4
Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review.克隆性造血、心血管疾病和癌症之间的联系:综述。
JAMA Cardiol. 2019 Apr 1;4(4):380-387. doi: 10.1001/jamacardio.2019.0302.
5
Murine models of clonal haematopoiesis to assess mechanisms of cardiovascular disease.评估心血管疾病发病机制的克隆性造血小鼠模型。
Cardiovasc Res. 2022 May 6;118(6):1413-1432. doi: 10.1093/cvr/cvab215.
6
Clonal hematopoiesis as a model for premalignant changes during aging.克隆性造血作为衰老过程中癌前变化的模型。
Exp Hematol. 2020 Mar;83:48-56. doi: 10.1016/j.exphem.2019.12.001. Epub 2019 Dec 12.
7
Advances in understanding the molecular basis of clonal hematopoiesis.克隆性造血分子基础认识的进展
Trends Mol Med. 2022 May;28(5):360-377. doi: 10.1016/j.molmed.2022.03.002. Epub 2022 Mar 25.
8
CHIP: is clonal hematopoiesis a surrogate for aging and other disease?CHIP:克隆性造血是否是衰老和其他疾病的替代指标?
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):384-389. doi: 10.1182/hematology.2021000270.
9
Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies.克隆性造血与向造血系统恶性肿瘤的演变。
Cell Stem Cell. 2018 Feb 1;22(2):157-170. doi: 10.1016/j.stem.2018.01.011.
10
How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?克隆性造血的发现对于骨髓增生异常综合征(MDS)或急性髓系白血病(AML)的发展有多大的预测性?
Best Pract Res Clin Haematol. 2021 Dec;34(4):101327. doi: 10.1016/j.beha.2021.101327. Epub 2021 Oct 23.

引用本文的文献

1
Multiplex PCR for the Rapid Diagnosis of Myeloproliferative Neoplasms.用于骨髓增殖性肿瘤快速诊断的多重聚合酶链反应
Methods Mol Biol. 2025;2960:39-55. doi: 10.1007/7651_2025_625.
2
Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms: a case-control study.年龄分层分析揭示动脉血栓形成是骨髓增殖性肿瘤中与性别相关的第二原发癌症的预测因素:一项病例对照研究。
Blood Cancer J. 2024 Apr 22;14(1):68. doi: 10.1038/s41408-024-01052-4.

本文引用的文献

1
Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.克隆性造血的不确定潜能 (CHIP) 与 2 型糖尿病发病风险。
Diabetes Care. 2023 Nov 1;46(11):1978-1985. doi: 10.2337/dc23-0805.
2
Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction.克隆性造血在射血分数保留的临床和实验性心力衰竭中的作用
Circulation. 2023 Oct 10;148(15):1165-1178. doi: 10.1161/CIRCULATIONAHA.123.064170. Epub 2023 Sep 8.
3
Clonal Hematopoiesis Has Prognostic Value in Dilated Cardiomyopathy Independent of Age and Clone Size.
克隆性造血与年龄和克隆大小无关,对扩张型心肌病具有预后价值。
JACC Heart Fail. 2024 May;12(5):905-914. doi: 10.1016/j.jchf.2023.06.037. Epub 2023 Aug 25.
4
Clonal hematopoiesis as a novel risk factor for type 2 diabetes mellitus in patients with hypercholesterolemia.克隆性造血作为高胆固醇血症患者 2 型糖尿病的新危险因素。
Front Public Health. 2023 Jun 28;11:1181879. doi: 10.3389/fpubh.2023.1181879. eCollection 2023.
5
Inflammation and aging: signaling pathways and intervention therapies.炎症与衰老:信号通路与干预治疗。
Signal Transduct Target Ther. 2023 Jun 8;8(1):239. doi: 10.1038/s41392-023-01502-8.
6
Evolution of age-related mutation-driven clonal haematopoiesis over 20 years is associated with metabolic dysfunction in obesity.20 年来,与年龄相关的突变驱动的克隆性造血的演变与肥胖中的代谢功能障碍有关。
EBioMedicine. 2023 Jun;92:104621. doi: 10.1016/j.ebiom.2023.104621. Epub 2023 May 18.
7
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.不定潜能克隆性造血预测动脉粥样硬化性心血管疾病患者的不良结局。
J Am Coll Cardiol. 2023 May 23;81(20):1996-2009. doi: 10.1016/j.jacc.2023.03.401.
8
Obesity-induced inflammation exacerbates clonal hematopoiesis.肥胖引起的炎症会加重克隆性造血。
J Clin Invest. 2023 Jun 1;133(11):e163968. doi: 10.1172/JCI163968.
9
Clonal haematopoiesis and risk of chronic liver disease.克隆性造血与慢性肝病风险。
Nature. 2023 Apr;616(7958):747-754. doi: 10.1038/s41586-023-05857-4. Epub 2023 Apr 12.
10
Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis.TCL1A 的异常激活促进克隆性造血中的干细胞扩增。
Nature. 2023 Apr;616(7958):755-763. doi: 10.1038/s41586-023-05806-1. Epub 2023 Apr 12.